Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor Gefitinib (ZD1839) and the monoclonal antibody Cetuximab (IMC-C225): Superiority over single-agent receptor targeting
- Matar, P.
- Rojo, F.
- Cassia, R.
- Moreno-Bueno, G.
- Di Cosimo, S.
- Tabernero, J.
- Guzmán, M.
- Rodriguez, S.
- Arribas, J.
- Palacios, J.
- Baselga, J.
ISSN: 1078-0432
Argitalpen urtea: 2004
Alea: 10
Zenbakia: 19
Orrialdeak: 6487-6501
Mota: Artikulua